Tuberculosis News and Research

Latest Tuberculosis News and Research

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

During the Fifth Decennial International Conference on Healthcare-Associated Infections, the Society for Healthcare Epidemiology of America and the Association for Professionals in Infection Control and Epidemiology awarded their first Partnership in Prevention Award to the National Guard Health Affairs in Saudi Arabia.

20 Mar 2010

New WHO report estimates 440,000 MDR-TB cases worldwide in 2008

There were an estimated 440,000 cases of multidrug-resistant tuberculosis (MDR-TB) around the world in 2008 - one-third of which were fatal, according to a new WHO report on drug-resistant TB, the Los Angeles Times reports (Maugh, 3/19).

20 Mar 2010

Report highlights gains in malaria fight, documents need for more funding

Global funding for efforts to fight malaria, which stood at $2 billion at the end of 2009, have "helped to contain the disease," but is "far short of the estimated $6 billion required annually to expand" efforts to fight it, the Roll Back Malaria Partnership said on Thursday, Reuters reports. The statements came as the partnership released a report (.pdf) that examined a decade's worth of global funding for malaria and its impact on fighting the disease (Hardach, 3/18).

20 Mar 2010

NMA to discuss the impact of health care reform on health disparities

The National Medical Association, the nation's oldest and largest organization representing the interests of 30,000 African American physicians will hold a press conference to address health care reform legislation and its impact on health disparities.

19 Mar 2010

Global initiative for reducing time taken to introduce new combination TB treatments

Ahead of World TB Day, US Food and Drug Administration Commissioner Margaret Hamburg helped public and private sector partners launch a new collaboration to significantly accelerate the development of combination treatments for tuberculosis — and replace an almost 50-year-old drug regimen. Created by the Global Alliance for TB Drug Development, the Critical Path Institute, and the Bill & Melinda Gates Foundation, the initiative could potentially reduce the time it takes to introduce new combination TB treatments from as much as a quarter century to as few as six years.

19 Mar 2010

Media outlets interview Shah during life sciences conference in Seattle

USAID Administrator Rajiv Shah was in Seattle on Tuesday to speak at the annual Life Science Innovation Northwest conference, the Seattle Times' blog, "The Business of Giving," reports. The blog outlines the Obama administration's global health and development goals, including the six-year $63 billion Global Health Initiative (GHI), as well as some of the challenges facing Shah at USAID.

19 Mar 2010

BioSense Technologies' Z-Sense Differential Impedance Sensing diagnostic system rapidly identifies drug susceptibility

BioSense Technologies, a pioneer in the development of diagnostic systems for rapid drug susceptibility testing, announced today that it presented key scientific findings at the National Foundation for Infection Disease 2010 Annual Conference on Antimicrobial Resistance, held in Bethesda, MD in early February.

19 Mar 2010

FDA drafts new rules for testing, approving drug cocktails; Public-private partnership for TB treatment development launched

The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations. Such drug cocktails can prevent the development of drug resistance, because the microbe or cancer cell needs to undergo more mutations to escape several drugs than to escape just one. By attacking the disease in different ways, drug combinations also improve the chances of therapeutic benefit," the newspaper reports (Schoofs, 3/18).

19 Mar 2010

WHO estimates 440 000 MDR-TB cases in 2008

In some areas of the world, one in four people with tuberculosis (TB) becomes ill with a form of the disease that can no longer be treated with standard drugs regimens, a World Health Organization (WHO) report says.

19 Mar 2010

Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.

18 Mar 2010

U.N. Secretary-General launches report aimed at meeting MDGs by 2015

U.N. Secretary-General Ban Ki-moon "warned on Tuesday that failure to meet" Millennium Development Goal (MDG) targets by the 2015 deadline could result in "increased instability, violence, epidemic diseases and overpopulation," Agence France-Presse/Mail & Guardian reports (3/17).

18 Mar 2010

Systemic underfunding of CDC's Division of Viral Hepatitis puts millions of Americans' health at risk

Warning that "systemic underfunding of the Centers for Disease Control's Division of Viral Hepatitis puts millions of Americans' health and well-being at risk," the National Viral Hepatitis Roundtable today called on the Administration to work with Congress to take decisive action this year to fix the funding failure for viral hepatitis screening, surveillance, and early intervention programs.

17 Mar 2010

Booster shot appears to improve TB resistance in previously vaccinated adults

A booster shot appears to improve tuberculosis (TB) resistance in previously vaccinated adults, according to new research in South Africa.

17 Mar 2010

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Monash Institute of Pharmaceutical Science researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that may benefit thousands of patients with particular types of cancer, HIV and lymphatic conditions world-wide.

15 Mar 2010

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Former President Bill Clinton and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, said Wednesday at a Senate Foreign Relations Committee hearing "that U.S. investments in fighting [HIV/]AIDS, malaria and other diseases in underdeveloped nations save lives and play a vital role in improving America's image abroad," the Associated Press reports.

12 Mar 2010

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

The Senate Finance Committee's chair, Max Baucus (D-Mont.), and top Republican, Charles Grassley (Iowa), are working with colleagues in the House on legislation that would lower tariffs in an effort to help Haiti's apparel industry and help the country recover from the major January earthquake, CQ Politics reports.

11 Mar 2010

British government, HIV/AIDS advocates warn decreased aid budgets could lead to reversals in HIV/AIDS treatment progress

Recent gains in the global fight against HIV/AIDS could be reversed as the "global economic downturn pinches poor countries' budgets and donors show signs of backing away from their promise to provide universal access to AIDS treatment," the British government together with Medecins Sans Frontieres warned Tuesday, Reuters AlertNet reports.

11 Mar 2010

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.

10 Mar 2010

Strong, local leadership is the key for success of health departments and activities

The surge of funds for bioterrorism preparedness over the past decade does not appear to be improving local public health resources in general, according to research from Purdue University.

10 Mar 2010

UNAIDS director cautions against funding cuts to Global Fund

During an appeal to government and private donors to pledge money to the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday, UNAIDS Executive Director Michel Sidibe warned of the repercussions tightening budgets could play in the global fight against HIV/AIDS, the Associated Press reports.

10 Mar 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

New WHO report estimates 440,000 MDR-TB cases worldwide in 2008

Report highlights gains in malaria fight, documents need for more funding

NMA to discuss the impact of health care reform on health disparities

Global initiative for reducing time taken to introduce new combination TB treatments

Media outlets interview Shah during life sciences conference in Seattle

BioSense Technologies' Z-Sense Differential Impedance Sensing diagnostic system rapidly identifies drug susceptibility

FDA drafts new rules for testing, approving drug cocktails; Public-private partnership for TB treatment development launched

WHO estimates 440 000 MDR-TB cases in 2008

Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series

U.N. Secretary-General launches report aimed at meeting MDGs by 2015

Systemic underfunding of CDC's Division of Viral Hepatitis puts millions of Americans' health at risk

Booster shot appears to improve TB resistance in previously vaccinated adults

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

British government, HIV/AIDS advocates warn decreased aid budgets could lead to reversals in HIV/AIDS treatment progress

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

Strong, local leadership is the key for success of health departments and activities

UNAIDS director cautions against funding cuts to Global Fund

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in